Probabilistic medicine: a pre-emptive approach is needed for cancer therapeutic risk mitigation

Biomark Med. 2019 Aug;13(12):987-990. doi: 10.2217/bmm-2019-0228. Epub 2019 Aug 6.
No abstract available

Keywords: genomics; pharmacogenomics; precision oncology.

Publication types

  • Editorial

MeSH terms

  • Antineoplastic Agents / adverse effects
  • Antineoplastic Agents / therapeutic use
  • Biomarkers, Tumor / genetics
  • Biomarkers, Tumor / metabolism
  • Humans
  • Mutation
  • Neoplasms / genetics
  • Neoplasms / metabolism
  • Neoplasms / mortality
  • Neoplasms / therapy*
  • Precision Medicine*

Substances

  • Antineoplastic Agents
  • Biomarkers, Tumor